- Home
- ANAB vs BMBL Comparison
ANAB vs BMBL Comparison
Compare ANAB & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANAB
- BMBL
- Stock Information
- Founded
- ANAB 2005
- BMBL 2014
- Country
- ANAB United States
- BMBL United States
- Employees
- ANAB N/A
- BMBL N/A
- Industry
- ANAB Biotechnology: Pharmaceutical Preparations
- BMBL Computer Software: Prepackaged Software
- Sector
- ANAB Health Care
- BMBL Technology
- Exchange
- ANAB Nasdaq
- BMBL Nasdaq
- Market Cap
- ANAB 630.2M
- BMBL 661.5M
- IPO Year
- ANAB 2017
- BMBL 2021
- Fundamental
- Price
- ANAB $21.90
- BMBL $6.70
- Analyst Decision
- ANAB Buy
- BMBL Hold
- Analyst Count
- ANAB 10
- BMBL 14
- Target Price
- ANAB $48.00
- BMBL $6.65
- AVG Volume (30 Days)
- ANAB 465.1K
- BMBL 4.3M
- Earning Date
- ANAB 11-04-2025
- BMBL 11-05-2025
- Dividend Yield
- ANAB N/A
- BMBL N/A
- EPS Growth
- ANAB N/A
- BMBL N/A
- EPS
- ANAB N/A
- BMBL N/A
- Revenue
- ANAB $123,164,000.00
- BMBL $1,030,583,000.00
- Revenue This Year
- ANAB $11.22
- BMBL N/A
- Revenue Next Year
- ANAB $8.35
- BMBL N/A
- P/E Ratio
- ANAB N/A
- BMBL N/A
- Revenue Growth
- ANAB 304.17
- BMBL N/A
- 52 Week Low
- ANAB $12.21
- BMBL $3.55
- 52 Week High
- ANAB $40.70
- BMBL $9.22
- Technical
- Relative Strength Index (RSI)
- ANAB 52.43
- BMBL 52.73
- Support Level
- ANAB $19.86
- BMBL $6.13
- Resistance Level
- ANAB $22.98
- BMBL $6.54
- Average True Range (ATR)
- ANAB 1.00
- BMBL 0.27
- MACD
- ANAB 0.35
- BMBL 0.03
- Stochastic Oscillator
- ANAB 69.14
- BMBL 92.22
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.